首页 | 本学科首页   官方微博 | 高级检索  
检索        

肌少症生物标志物的研究进展
引用本文:王湾湾,马清.肌少症生物标志物的研究进展[J].中华老年多器官疾病杂志,2019,18(11):877-880.
作者姓名:王湾湾  马清
作者单位:首都医科大学附属北京友谊医院医疗保健中心,北京 100050,首都医科大学附属北京友谊医院医疗保健中心,北京 100050
摘    要:肌少症是一种由衰老引起的进行性骨骼肌肉量、肌肉力量和功能下降的老年综合征。肌少症十分常见,但经常被忽视且未得到合适的治疗。有效的生物标志物可促进肌少症的早期诊断和预后,为此本文结合文献综述了近年有关肌少症生物标志物的研究进展。

关 键 词:  骨骼  肌疾病  肌少症

Research progress on biomarkers of sarcopenia
WANG Wan-Wan and MA Qing.Research progress on biomarkers of sarcopenia[J].Chinrse journal of Multiple Organ Diseases in the Elderly,2019,18(11):877-880.
Authors:WANG Wan-Wan and MA Qing
Institution:Center of Medical Care and Health, Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing 100050, China and Center of Medical Care and Health, Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing 100050, China
Abstract:Sarcopenia is a geriatric syndrome of progressive decline in skeletal muscle mass, muscle strength and muscle function due to aging. Sarcopenia is very common but frequently overlooked and undertreated. Effective biomarker can enhance its early diagnosis and prognosis. For that purpose, this parper reviews progress in biomarkers for sarcopenia in recent years.
Keywords:
本文献已被 CNKI 等数据库收录!
点击此处可从《中华老年多器官疾病杂志》浏览原始摘要信息
点击此处可从《中华老年多器官疾病杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号